The first cellular therapy for type 1 diabetes, called Lantidra, was approved by the Food and Drug Administration (FDA) for use in the United States. This is potentially good news for the 1.9 million people in the United States living with type 1 diabetes. The FDA approved the drug on June 28, after two clinical…